Pfizer Seeks Authorization Of COVID-19 Vaccine For Children Under Five

The Washington Post (6/1) reports Pfizer on Wednesday completed submitting its “application for regulatory authorization of a coronavirus vaccine for children younger than 5.” The announcement “comes a week after Pfizer and BioNTech announced that three shots of their low-dose pediatric vaccine triggered a robust immune response in young children and was safe. The companies began sending data to the Food and Drug Administration in February.”

The Hill (6/1) reports, “The FDA’s vaccine advisory committee is slated to meet on June 15 to look at expanding the Pfizer-BioNTech emergency use authorization to include children under the age of 5, and Pfizer said its clinical data would be reviewed during that meeting.”

FURTHER READING

Pfizer to submit data to FDA on COVID19 vaccine for children under 5